Benchling revenue, valuation & funding | Sacra
Benchling
Overview
Software for biotech teams to design, document, and manage scientific experiments and samples.
Revenue
- 2023 Revenue: $185.00M
- 2024 Valuation: $6.10B
- 2024 Funding: $412.00M
- 2024 Growth Rate (y/y): 27%
Details
- Headquarters: San Francisco, United States
- CEO: Sajith Wickramasekara
- Website: benchling.com
Milestones
- Founding Year: 2012
Revenue Summary
Benchling Data Summary
Annual Recurring Revenue (ARR) & Growth Rate
- ARR: $185.0M
- ARR Growth: ↑ 27.6% YoY
Financial Data
Valuation & Funding Summary
- Valuation: $6.1B
- Total Amount Raised: $412 million
Valuation & Funding History
| Date | Event | Valuation | Amount | Price | Status |
|---|---|---|---|---|---|
| Nov 2021 | Series F | $6.1B | $100M | $32.70 | Closed |
| Apr 2021 | Series E | — | — | — | Closed |
| May 2020 | Series D | — | — | — | Closed |
| Jul 2019 | Series C | — | — | — | Closed |
| Jun 2018 | Series B | — | — | — | Closed |
| Oct 2016 | Series A | — | — | — | Closed |
| Apr 2015 | Seed | — | — | — | Closed |
| Feb 2014 | Seed | — | — | — | Closed |
Product Overview
Benchling provides a suite of software tools designed to streamline and optimize the entire biotech R&D lifecycle, including:
- Experiment Design and Documentation
- Sample Tracking and Management
- Workflow Orchestration and Collaboration
- Data Capture, Analysis, and Visualization
Core Modules
- Notebook: Digital lab notebook.
- Molecular Biology: Tools for designing and analyzing sequences.
- Registry: Database for tracking biological entities.
- Inventory: Tracks storage and usage of lab materials.
- Workflows: Orchestrates complex R&D processes.
Benchling AI
Benchling AI, with free access for academic scientists, includes tools like Deep Research and Compose, enhancing research efficiency.
Business Model
Benchling operates on a SaaS model, providing a predictable revenue stream through subscription fees.
Competition
- Legacy Players: Players like Dassault Systèmes and Thermo Fisher Scientific are primary competitors, though they often lack the flexibility and integration offered by Benchling.
- Startups: Emerging companies like Riffyn and TetraScience also compete in the cloud software space.
Total Addressable Market Expansion
The Bioeconomy Revolution
The bioeconomy is expected to transform sectors, making Benchling’s offerings critical in this landscape.
The Rise of Synthetic Biology
Benchling is well-positioned to support the fast-growing synthetic biology industry, aiding innovation across multiple sectors.
Recent News
Benchling Launches Model Hub
On May 13, 2026, Benchling positions itself for enhanced AI-driven biotech innovation, potentially accelerating drug development.